GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $18,000 | – | 83 | +1283.3% | 0.00% | – |
Q4 2020 | $0 | -100.0% | 6 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | -66.7% | 6 | -60.0% | 0.00% | – |
Q3 2018 | $3,000 | +50.0% | 15 | 0.0% | 0.00% | – |
Q2 2018 | $2,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q1 2018 | $2,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q4 2017 | $2,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q3 2017 | $2,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q2 2017 | $2,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | 0.0% | 15 | 0.0% | 0.00% | – |
Q4 2016 | $2,000 | -81.8% | 15 | -90.9% | 0.00% | – |
Q4 2015 | $11,000 | +22.2% | 165 | +65.0% | 0.00% | – |
Q3 2015 | $9,000 | -25.0% | 100 | 0.0% | 0.00% | – |
Q2 2015 | $12,000 | +33.3% | 100 | 0.0% | 0.00% | – |
Q1 2015 | $9,000 | +28.6% | 100 | 0.0% | 0.00% | – |
Q4 2014 | $7,000 | -56.2% | 100 | -50.0% | 0.00% | – |
Q3 2014 | $16,000 | +45.5% | 200 | +100.0% | 0.00% | – |
Q2 2014 | $11,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |